WW International [WW] vs Medifast [MED] Detailed Stock Comparison

WW International Inc.

NASDAQ

Medifast Inc.

NYSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: WW International Inc. wins in 13 metrics, Medifast Inc. wins in 4 metrics, with 0 ties. WW International Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	WW International Inc.	Medifast Inc.	Better
P/E Ratio (TTM)	1.23	531.50	WW International Inc.
Price-to-Book Ratio	0.29	0.57	WW International Inc.
Debt-to-Equity Ratio	147.33	5.38	Medifast Inc.
PEG Ratio	-16.02	-0.22	Medifast Inc.
EV/EBITDA	2.70	-1,469.18	WW International Inc.
Profit Margin (TTM)	148.60%	-4.84%	WW International Inc.
Operating Margin (TTM)	-5.38%	-10.39%	WW International Inc.
Return on Equity	332.00%	-9.13%	WW International Inc.
Return on Assets (TTM)	6.74%	-3.34%	WW International Inc.
Free Cash Flow (TTM)	$-46.38M	$1.25M	Medifast Inc.
1-Year Return	6,292.31%	-10.95%	WW International Inc.
Price-to-Sales Ratio (TTM)	0.13	0.32	WW International Inc.
Enterprise Value	$401.21M	$-42.61M	WW International Inc.
EV/Revenue Ratio	0.57	-0.11	WW International Inc.
Gross Profit Margin (TTM)	70.08%	69.43%	WW International Inc.
Revenue per Share (TTM)	$16	$35	Medifast Inc.
Earnings per Share (Diluted)	$7.58	$-1.70	WW International Inc.
Beta (Stock Volatility)	N/A	0.56	N/A
Short % of Float	N/A	19.31%	N/A

WW International Inc. vs Medifast Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
WW International Inc.	7.04%	0.94%	58.20%	-25.18%	-33.41%	-45.10%
Medifast Inc.	0.25%	-6.69%	15.43%	14.57%	12.98%	17.98%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
WW International Inc.	6,292.31%	131.15%	-58.43%	9.85%	-78.19%	-60.76%
Medifast Inc.	-10.95%	-85.01%	-95.99%	-61.95%	-51.02%	-36.36%

Performance & Financial Health Analysis: WW International Inc. vs Medifast Inc.

Metric	WW	MED
Market Information
Market Cap i	$92.67M	$121.13M
Market Cap Category	Micro cap	Micro cap
10 Day Avg. Volume i	340,575	240,387
90 Day Avg. Volume i	412,935	275,592
Last Close	$17.26	$12.27
52 Week Range	$8.36 - $46.95	$9.22 - $15.46
% from 52W High	-63.23%	-20.63%
All-Time High	$105.73 (Jun 18, 2018)	$336.99 (May 24, 2021)
% from All-Time High	-83.68%	-96.36%
Growth Metrics
Quarterly Revenue Growth	-0.12%	-0.37%
Quarterly Earnings Growth	-0.19%	-0.37%
Financial Health
Profit Margin (TTM) i	1.49%	-0.05%
Operating Margin (TTM) i	-0.05%	-0.10%
Return on Equity (TTM) i	3.32%	-0.09%
Debt to Equity (MRQ) i	147.33	5.38
Cash & Liquidity
Book Value per Share (MRQ)	$31.83	$19.29
Cash per Share (MRQ)	$16.03	$16.22
Operating Cash Flow (TTM) i	$-28,897,000	$6.86M
Levered Free Cash Flow (TTM) i	$23.84M	$5.41M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	$0.00

Valuation & Enterprise Metrics Analysis: WW International Inc. vs Medifast Inc.

Metric	WW (Apr 26, 2026)	MED (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i	1.23	531.50
Forward P/E i	-16.02	-4.00
PEG Ratio i	-16.02	-0.22
Price to Sales (TTM) i	0.13	0.32
Price to Book (MRQ) i	0.29	0.57
Market Capitalization
Market Capitalization i	$92.67M	$121.13M
Enterprise Value i	$401.21M	$-42,606,284
Enterprise Value Metrics
Enterprise to Revenue i	0.57	-0.11
Enterprise to EBITDA i	2.70	-1,469.18
Risk & Other Metrics
Beta i	N/A	0.56
Book Value per Share (MRQ) i	$31.83	$19.29

Financial Statements Comparison: WW International Inc. vs Medifast Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric	WW (2025)	MED (2025)
Revenue/Sales i	710.64M	385.79M
Cost of Goods Sold i	200.14M	110.60M
COGS % of Revenue i	28.2%	28.7%
Gross Profit i	510.50M	275.19M
Gross Margin i	71.8%	71.3%
Research & Development i	42.39M	N/A
Operating Income (EBIT) i	46.43M	-14.21M
Operating Margin i	6.5%	-3.7%
EBITDA i	106.18M	29,000
EBITDA Margin i	14.9%	0.0%
Pre-Tax Income i	1.09B	-5.64M
Pre-Tax Income % of Revenue i	153.6%	-1.5%
Income Tax i	35.45M	13.03M
Income Tax % of Revenue i	5.0%	3.4%
Net Income (Profit) i	1.06B	-18.67M
Profit Margin i	148.6%	-4.8%

Balance Sheet & Liquidity Metrics

Metric	WW (2025)	MED (2025)
Cash & Equivalents i	160.28M	89.30M
Total Current Assets i	213.60M	201.68M
Total Current Assets % of Revenue i	30.1%	52.3%
Total Current Liabilities i	126.54M	42.96M
Total Current Liabilities % of Revenue i	17.8%	11.1%
Long-Term Debt i	467.36M	N/A
Long-Term Debt % of Revenue i	65.8%	0.0%
Total Shareholders Equity i	318.07M	198.92M
Retained Earnings i	-62.10M	158.27M
Retained Earnings % of Revenue i	-8.7%	41.0%
Property, Plant & Equipment i	18.08M	7.23M

Cash Flow Statement Comparison

Metric	WW (2025)	MED (2025)
Operating Cash Flow i	-63.85M	8.92M
Operating Cash Flow % of Revenue i	-9.0%	2.3%
Capital Expenditures i	N/A	-5.61M
Free Cash Flow i	-46.38M	1.25M
FCF Margin i	-6.5%	0.3%
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	-369,000

Short Interest & Institutional Ownership Analysis

Metric	WW	MED
Shares Short i	1.49M	2.06M
Short Ratio i	4.70	7.14
Short % of Float i	N/A	19.31%
Shares Outstanding i	10.00M	10.99M
Float Shares i	7.79M	8.48M
% Held by Insiders i	0.38%	3.86%
% Held by Institutions i	66.59%	78.14%
% Held by Public i	33.03%	18.00%

Dividend Analysis & Yield Comparison: WW International Inc. vs Medifast Inc.

Metric	WW	MED
Last 12-Month Dividend i	N/A	$0.00
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	$2.74
3-Year Avg Dividend Yield i	N/A	1.43%
3-Year Total Dividends i	N/A	$8.22
Ex-Dividend Date	N/A	Jun 26, 2023

Metric	WW (Dec 31, 2025)	MED (Dec 31, 2025)
Revenue/Sales i	162.81M	75.10M
Cost of Goods Sold i	48.72M	22.96M
COGS % of Revenue i	29.9%	30.6%
Gross Profit i	114.10M	52.14M
Gross Margin i	70.1%	69.4%
Research & Development i	8.87M	N/A
Operating Income (EBIT) i	-12.94M	-7.80M
Operating Margin i	-7.9%	-10.4%
EBITDA i	13.39M	-4.34M
EBITDA Margin i	8.2%	-5.8%
Pre-Tax Income i	-24.69M	-6.38M
Pre-Tax Income % of Revenue i	-15.2%	-8.5%
Income Tax i	-18.86M	11.74M
Income Tax % of Revenue i	-11.6%	15.6%
Net Income (Profit) i	-5.83M	-18.12M
Profit Margin i	-3.6%	-24.1%

WW International [WW] vs Medifast [MED] Detailed Stock Comparison

WW International Inc.

Medifast Inc.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete WW International Inc. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

WW International Inc. vs Medifast Inc. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: WW International Inc. vs Medifast Inc.

Valuation & Enterprise Metrics Analysis: WW International Inc. vs Medifast Inc.

Financial Statements Comparison: WW International Inc. vs Medifast Inc.

Financial Metrics

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

WW (Annual)

WW (Quarterly)

MED (Annual)

MED (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: WW International Inc. vs Medifast Inc.

Metric	WW (Dec 31, 2025)	MED (Dec 31, 2025)
Cash & Equivalents i	170.15M	89.30M
Total Current Assets i	219.32M	201.68M
Total Current Assets % of Revenue i	134.7%	268.6%
Total Current Liabilities i	132.96M	42.96M
Total Current Liabilities % of Revenue i	81.7%	57.2%
Long-Term Debt i	467.69M	6.09M
Long-Term Debt % of Revenue i	287.3%	8.1%
Total Shareholders Equity i	322.99M	198.92M
Retained Earnings i	-56.26M	158.27M
Retained Earnings % of Revenue i	-34.6%	210.8%
Property, Plant & Equipment i	12.12M	7.23M

Metric	WW (Dec 31, 2025)	MED (Dec 31, 2025)
Operating Cash Flow i	15.82M	-3.24M
Operating Cash Flow % of Revenue i	9.7%	-4.3%
Capital Expenditures i	N/A	-1.35M
Free Cash Flow i	-10.35M	-6.63M
FCF Margin i	-6.4%	-8.8%
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	1,000

WW International [WW] vs Medifast [MED] Detailed Stock Comparison

WW International Inc.

Medifast Inc.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete WW International Inc. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

WW International Inc. vs Medifast Inc. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: WW International Inc. vs Medifast Inc.

Valuation & Enterprise Metrics Analysis: WW International Inc. vs Medifast Inc.

Financial Statements Comparison: WW International Inc. vs Medifast Inc.

Financial Metrics Quarterly Annual

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

WW (Annual)

WW (Quarterly)

MED (Annual)

MED (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: WW International Inc. vs Medifast Inc.

Financial Metrics